Navigation Links
Neuralstem Sues StemCells, Inc. Over New Patent
Date:5/7/2008

ology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia.

Major Central Nervous System diseases targeted by the Company with research programs currently underway include: Ischemic Paraplegia, Traumatic Spinal Cord Injury and ALS. The company's cells have extended the life of rats with ALS (Lou Gehrig's disease) as reported the journal TRANSPLANTATION, in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in collaboration with researchers at University of California San Diego.

The company has also developed immortalized human neural stem cells for in-vitro use in drug development for the academic and pharmaceutical markets. For further information, please visit http://www.neuralstem.com.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward- looking statements. Additional information on potential factors that could aff
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
2. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. Neuralstem Shares Accepted for Trading on Amex(R)
5. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
6. Japan Patent Office Licenses GeneCards(R) from Xennex, Inc.
7. ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
8. Signalife Awarded New U.S. Patent, System For, And Method Of, Monitoring Heartbeats Of A Patient
9. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
10. Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
11. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ndpointhasbeenmetforpatientswithadvanced-stage,orr...4/PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ...ticalcompanyfocusedonendocrinetherapyandoncology,t...ithitstargetedcytotoxicpeptideconjugate,AEZS-108(f...dometrialcancer.Inapersonalizedhealthcareapproach,...
(Date:11/24/2009)...2009/PRNewswire-FirstCall/--ArenaPharmaceuticals,I...scheduledtopresentatthePiperJaffray21stAnnualHealt...ime(8:30a.m.PacificTime)attheNewYorkPalaceHotelinN...utiveOfficer,isscheduledtoprovideanoverviewoftheco...rograms. ,, Aliveaudiowebcastofthepresentationw...
(Date:11/24/2009)... Program Connects Customers with Partners Validat...NA Genotek Products , Ott..., a leading provider of products for biological sa...day announced its new global partner program. The ...notek,s partner community and is designed to help ...
(Date:11/23/2009)...23, 2009 In a provocative new study, a University...de emissions the major cause of global warming c...lapses or society builds the equivalent of one new...kely that there will be any substantial near-term ...arbon dioxide emission rates," says the new paper ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...edarex, Inc. (Nasdaq: MEDX ) announced today tha... are expected to be the subject of poster presenta...ation for Cancer Research (AACR), being held April...ase I, open-label, dose-escalation, multi-dose stu...lonal antibody) in patients with CD30-positive ref...
... Magellan Biosciences, an emerging leader in syste...t & Sullivan 2009 North American Product Innov...e test that enables children and adults to be scre...onveniently. Magellan,s President of Clinical Diag...row night at the 2009 Excellence in Medical Techno...
...ch 17 The Healthcare and Science business of Th...nnual roundup of the "hottest" researchers and res...e Watch , Thomson Reuters identified the top 13 au...s in 2007-2008 as well as the most-cited research ...horing multiple Hot Papers serves to highlight res...
Other Biology Technology:Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research 2Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 2Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 3Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 4Thomson Reuters Names 'Hottest' Researchers and Papers of 2007-2008 2
(Date:11/23/2009)...on, D.C. The community-associated strain of the d...esistant to most common antibioticsposes a far gre...king its way into hospitals, according to a study ...ases . , The new threat is easily picked up in ...and has increased the overall burden of MRSA withi...
(Date:11/23/2009)...study by the Wildlife Conservation Society says th...p in the Republic of Congopart of the "mother lode...arare becoming increasingly threatened by growing ...mends protection of the swamp forests adjacent to ...fter recent surveys confirmed that high densities ...
(Date:11/23/2009)...IGN, Ill. A new study provides "incontrovertible ... on the island of Sumatra about 73,000 years ago d...from the epicenter, researchers report. , The vo... ash into the atmosphere, leaving a crater (now th...eters long and 35 kilometers wide. Ash from the ev...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Global Gathering for Contact Center Professionals to Focus On Thinking Forward The Power of the Customer Experience at ICMIs Annual Call Center Exhi 56601 1Global Gathering for Contact Center Professionals to Focus On Thinking Forward The Power of the Customer Experience at ICMIs Annual Call Center Exhi 56601 2Global Gathering for Contact Center Professionals to Focus On Thinking Forward The Power of the Customer Experience at ICMIs Annual Call Center Exhi 56601 3Morrisey Associates Helps Healthcare Organizations Improve Patient Management Outside the Acute Care Setting 56599 1Morrisey Associates Helps Healthcare Organizations Improve Patient Management Outside the Acute Care Setting 56599 2Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 1Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 2
...ble biomedical devices that can act as artificial ...se paralyzed muscles to be moved might one day be ...ce. Writing today in Advanced Materials, Nicholas ...eagues describe how they have used hollow, submicr...nnect an integrated circuit to nerve cells. The ne...
...nd other "impotence drugs" that boost the producti...essels and produce an erection now also show promi...stem can recognize and attack them, say scientists...s at Hopkins on mice with implanted colon and brea...d threefold in sildenafil-treated animals, compare...
...omaviruses (HPV) are the most common sexually tran...in "high risk" types have been shown to cause cerv...tion and prevention of HPV, the link between the v...public. In June 2006, the Food and Drug Administr...infection of two high risk types of HPV, and two t...
Other Biology News:Neural networking nanotubes 2'Erectile dysfunction' drugs heighten natural anti-cancer activity 2What does the public really know about HPV? 2What does the public really know about HPV? 3What does the public really know about HPV? 4
6-Tube Magnetic Separation Rack from New England Biolabs
... at the 9, 10, 12, and 13 positions. It is intende...cation of 9(S)-HODE by GC- or LC-mass spectrometry...inoleic acid in both plants and animals. It has be...rified component of membrane phospholipids and in ...
5(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
Biology Products: